A major advance in cancer study is occurring with the use of VHH fragments to restore dysfunctional p53. This essential malignant protector protein is frequently disabled in various types of cancer, resulting https://nanobookmarking.com/story21846906/mini-antibodies-reactivate-p53-a-promising-approach-for-cancer-treatment